Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

485
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
485
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

287
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
287

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of a Polygenic Risk Score with Diagnosis and Outcomes in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Paraseptal Emphysema and Interstitial Lung Abnormalities in AGES-Reykjavik Study.

Annals of the American Thoracic Society·2026
Same author

Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular Programs.

bioRxiv : the preprint server for biology·2026
Same author

KLF4 Initiates Dedifferentiation of Systemic Sclerosis Lung Fibroblasts.

Cells·2026
Same author

A Radiogenomic Model using MRI and Gene Signature to Predict Complete Response in Breast Cancer.

European journal of radiology·2026
Same author

A weakly supervised transformer for rare disease diagnosis and subphenotyping from EHRs with pulmonary case studies.

NPJ digital medicine·2026

Related Experiment Video

Updated: Sep 2, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.1K

Suspected Interstitial Lung Disease in COPDGene Study.

Jonathan A Rose1, Aravind A Menon1, Takuya Hino2

  • 1Pulmonary and Critical Care Division.

American Journal of Respiratory and Critical Care Medicine
|August 5, 2022
PubMed
Summary

Interstitial lung disease (ILD) in patients with interstitial lung abnormalities (ILA) is linked to worse health outcomes and higher mortality. Identifying suspected ILD is crucial for understanding its impact on lung function and patient prognosis.

Keywords:
interstitial lung abnormalitiesinterstitial lung diseasepulmonary fibrosis

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

535
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.8K

Related Experiment Videos

Last Updated: Sep 2, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.1K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

535
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.8K

Area of Science:

  • Pulmonology
  • Radiology
  • Epidemiology

Background:

  • Interstitial lung abnormalities (ILA) on CT scans are linked to poor lung function and mortality.
  • The specific contribution of interstitial lung disease (ILD) within ILA to these adverse outcomes remains unclear.

Purpose of the Study:

  • To determine the prevalence and risk factors of suspected ILD in individuals with ILA.
  • To assess the association of suspected ILD with clinical outcomes, including lung function, exacerbations, and mortality.

Main Methods:

  • The COPDGene study cohort was used, defining suspected ILD as ILA plus fibrosis, reduced FVC, or reduced DLCO.
  • Multivariable regression models analyzed associations with quality of life (SGRQ), exercise capacity (6MWT), oxygen use, exacerbations, and mortality.

Main Results:

  • 5% of participants had suspected ILD, and 5% had ILA without suspected ILD.
  • Suspected ILD was associated with worse SGRQ scores, reduced 6MWT distance, increased oxygen use, more severe exacerbations, and higher mortality compared to ILA alone.
  • Risk factors for suspected ILD included Black race and smoking history.

Conclusions:

  • Suspected ILD affects half of individuals with ILA in the COPDGene cohort.
  • Suspected ILD is significantly associated with decrements in exercise capacity, increased symptoms, higher rates of oxygen use and exacerbations, and increased mortality.